Western blotting experiments were performed as previously described
[24] (link). The antibodies used in this research were as follows: anti-human β-actin (AF7018; Affinity Biosciences, Cincinnati, USA), anti-human G6PD (ab210702; Abcam, Cambridge, UK), anti-human TP53 (9282; Cell Signaling Technology, Boston, USA), anti-human E-cadherin (ab231303; Abcam), anti-human N-cadherin (ab207608; Abcam), anti-human MMP-9 (AF5228; Affinity Biosciences), anti-human Bcl-2 (AF6139; Affinity Biosciences), anti-human cleaved caspase-3 (AF7022; Affinity Biosciences), anti-human Cyt-C (AF0146; Affinity Biosciences), and anti-human YY1 (ABP60802; Abbkine, Wuhan, China).
[24] (link). The antibodies used in this research were as follows: anti-human β-actin (AF7018; Affinity Biosciences, Cincinnati, USA), anti-human G6PD (ab210702; Abcam, Cambridge, UK), anti-human TP53 (9282; Cell Signaling Technology, Boston, USA), anti-human E-cadherin (ab231303; Abcam), anti-human N-cadherin (ab207608; Abcam), anti-human MMP-9 (AF5228; Affinity Biosciences), anti-human Bcl-2 (AF6139; Affinity Biosciences), anti-human cleaved caspase-3 (AF7022; Affinity Biosciences), anti-human Cyt-C (AF0146; Affinity Biosciences), and anti-human YY1 (ABP60802; Abbkine, Wuhan, China).
